These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14768988)

  • 41. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).
    Zeferino LC; Rabelo-Santos SH; Villa LL; Sarian LO; Costa MC; do Amaral Westin MC; de Ângelo-Andrade LA; Derchain S
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):160-4. PubMed ID: 21680079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
    CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Aydogan Kirmizi D; Baser E; Demir Caltekin M; Onat T; Sahin S; Yalvac ES
    Diagn Cytopathol; 2021 Jan; 49(1):132-139. PubMed ID: 33118711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy.
    Antonishyn NA; Horsman GB; Kelln RA; Severini A
    Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
    Wong AK; Chan RC; Nichols WS; Bose S
    Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
    Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
    Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-risk human papillomavirus deoxyribonucleic acid as an adjunct marker in cervical cytology.
    Lin CT; Tseng CJ; Chou HH; Huang KG; Chang TC; Lai HH; Soong YK
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):409-15. PubMed ID: 10584412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
    Mayrand MH; Duarte-Franco E; Rodrigues I; Walter SD; Hanley J; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    N Engl J Med; 2007 Oct; 357(16):1579-88. PubMed ID: 17942871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management.
    Lee SJ; Jung KL; Lee JW; Song SY; Kim BG; Lee JH; Park CS; Bae DS
    Int J Gynecol Cancer; 2006; 16(2):664-9. PubMed ID: 16681744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
    Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
    JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep Pap tests.
    Rowe LR; Aldeen W; Bentz JS
    Diagn Cytopathol; 2004 Jun; 30(6):426-32. PubMed ID: 15176032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion" : an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice.
    Bonvicino A; Huitron S; Fadare O
    Cancer; 2007 Dec; 111(6):477-81. PubMed ID: 17932941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Derchain SF; Rabelo-Santos SH; Sarian LO; Zeferino LC; de Oliveira Zambeli ER; do Amaral Westin MC; de Angelo Andrade LA; Syrjänen KJ
    Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
    Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice.
    Armah H; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2009 Sep; 133(9):1426-30. PubMed ID: 19722749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.